Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb44af5db125eb6b0781af540ac7257a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43ba47d318b66f16bf48f46f459e9625 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001171 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
1994-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e616d28a1c64f327ffa5185ad4c367f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d62c32afca995b1821192b312afbd694 |
publicationDate |
1994-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9416731-A1 |
titleOfInvention |
Ganglioside-klh conjugate vaccines with qs-21 |
abstract |
This invention provides a vaccine for stimulating or enhancing the production of an antibody which recognizes a ganglioside in a subject to which the vaccine is administered. The vaccine is comprised of an amount of ganglioside or oligosaccharide portion thereof conjugated to an immunogenic protein effective to stimulate or enhance antibody production in the subject. The vaccine is further comprised of an adjuvant and a pharmaceutically acceptable vehicle. The invention also provides a method of using the vaccine for treating or preventing cancer wherein gangliosides are on the surface or in the stroma of the cancer cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5977316-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9644025-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964192-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0661061-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9856420-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7794713-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363305-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1099894-C http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8128928-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8535673-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9067981-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7790856-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7517967-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9051363-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0661061-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8003097-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6509016-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5935821-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786586-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6355244-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1017419-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1017419-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642044-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1903114-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6814981-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5854069-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8808692-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7862812-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916165-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1731161-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8034348-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8034339-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8613920-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8784810-B2 |
priorityDate |
1993-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |